NCT04911582View on ClinicalTrials.gov

Does the Bioactive Substance in Coffee, Cafestol, Have Preventive Properties on Type-2-diabetes? (Acute Substudy)

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions
Obesity, Abdominal
Interventions
DIETARY_SUPPLEMENT

Cafestol 12 mg

Capsule with 12 mg cafestol

DIETARY_SUPPLEMENT

Placebo

Placebo capsule without cafestol

DIETARY_SUPPLEMENT

Cafestol 6 mg

Capsule with 6 mg cafestol

Trial Locations (1)

8200

Steno Diabetes Center Aarhus, Aarhus

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

lead

University of Aarhus

OTHER